ArticleJournal of Cancer2024

Neoadjuvant targeted immunotherapy followed by surgical resection versus upfront surgery for hepatocellular carcinoma with macrovascular invasion: A multicenter study.

Xiang'an Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.